| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $6.86 | $1.29 | $3.58 | $4.28 | $1.20 | $1.14 | $1.42 | $1.38 |
| EPS (Diluted) | $6.79 | $1.28 | $3.54 | $4.23 | $1.19 | $1.14 | $1.42 | $1.38 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $31.5B | $30.7B | $28.4B | $28.4B | $34.7B | $37.7B | $32.5B | $28.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | $4.4B | $3.1B |
| Total Liabilities | $27.9B | $27.4B | $25.2B | $25.4B | $31.5B | $34.9B | $29.7B | $25.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.6B | $3.4B | $3.2B | $3.1B | $3.2B | $2.9B | $2.8B | $2.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.5B | $0.4B | $0.1B | $0.7B | $2.6B | $-0.2B | $-0.7B |
| Investing Cash Flow | $-1.9B | $-2.5B | $-1.8B | $3.3B | $1.2B | $-2.9B | $-2.3B | $-2.0B |
| Capital Expenditures | $0.0B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.4B | $1.9B | $-0.4B | $-6.4B | $-3.1B | $5.1B | $3.9B | $2.8B |